menu

AHA 2020: New Insights on Iron Deficiency and Heart Failure

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

AHA 2020: New Insights on Iron Deficiency and Heart Failure

close
0.25 credits
15 minutes
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
0.25 credits
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    We know that approximately 70% of patients hospitalized with heart failure are iron deficient. Iron deficiency independent from anemia is associated with poor exercise capacity, poor quality of life, and increased mortality in these patients. How can you reduce the risk of rehospitalization and improve outcomes for these iron deficient patients with acute heart failure? 

    This expert panel discusses the latest data from AHA 2020 around the role of iron deficiency and its correction in hospitalized patients stabilized after an episode of acute heart failure.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Javed Butler, MD, MPH, MBA
    Professor & Chair, Department of Medicine
    University of Mississippi Medical Center
    Jackson, MS 

    Consulting Fees: Abbott, Adrenomed, Amgen, Array, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CVRx, G3 Pharmaceuticals, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, Novo Nordisk, Relypsa, Roche, V-Wave Ltd., Vifor Pharma

    Faculty:
    Gerasimos Filippatos, MD, FESC, FHFA
    Head of the Heart Failure Unit at the Department of Cardiology
    Athens University Hospital Attikon
    Chaidari, Greece 

    Consulting Fees: Boehringer Ingelheim, Servier
    Commercial Interest Speakers Bureau: Boehringer Ingelheim, Novartis
    Contracted Research: Amgen, Bayer, Vifor Pharma

    Piotr Ponikowski, MD, PHD, FESC, FHFA
    Medical University, Centre for Heart Disease
    Clinical Military Hospital
    Wroclaw, Poland 

    Consulting Fees: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Berlin Chemie, Cardiorentis, Cibiem, Coridea, Fresenius, Impulse Dynamics, Novartis, Pfizer, RenalGuard Solutions, Servier, Vifor Pharma

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Ben Caref, PhD, has nothing to disclose.
    • Megan Clem has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Stephanie Wenick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Evaluate new data on the management of iron deficiency in acute decompensated heart failure.
    • Identify clinical practice changes for the management of iron deficiency in acute decompensated heart failure based on new data. 
  • Target Audience

    This activity is designed to meet the educational needs of heart failure specialists, cardiologists, primary care physicians, nephrologists, and all other allied healthcare professionals involved in the diagnosis, treatment, and care of heart failure.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.

  • Commercial Support

    This activity is supported by an independent educational grant from Vifor Pharma.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    We know that approximately 70% of patients hospitalized with heart failure are iron deficient. Iron deficiency independent from anemia is associated with poor exercise capacity, poor quality of life, and increased mortality in these patients. How can you reduce the risk of rehospitalization and improve outcomes for these iron deficient patients with acute heart failure? 

    This expert panel discusses the latest data from AHA 2020 around the role of iron deficiency and its correction in hospitalized patients stabilized after an episode of acute heart failure.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Javed Butler, MD, MPH, MBA
    Professor & Chair, Department of Medicine
    University of Mississippi Medical Center
    Jackson, MS 

    Consulting Fees: Abbott, Adrenomed, Amgen, Array, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CVRx, G3 Pharmaceuticals, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, Novo Nordisk, Relypsa, Roche, V-Wave Ltd., Vifor Pharma

    Faculty:
    Gerasimos Filippatos, MD, FESC, FHFA
    Head of the Heart Failure Unit at the Department of Cardiology
    Athens University Hospital Attikon
    Chaidari, Greece 

    Consulting Fees: Boehringer Ingelheim, Servier
    Commercial Interest Speakers Bureau: Boehringer Ingelheim, Novartis
    Contracted Research: Amgen, Bayer, Vifor Pharma

    Piotr Ponikowski, MD, PHD, FESC, FHFA
    Medical University, Centre for Heart Disease
    Clinical Military Hospital
    Wroclaw, Poland 

    Consulting Fees: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Berlin Chemie, Cardiorentis, Cibiem, Coridea, Fresenius, Impulse Dynamics, Novartis, Pfizer, RenalGuard Solutions, Servier, Vifor Pharma

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Ben Caref, PhD, has nothing to disclose.
    • Megan Clem has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Stephanie Wenick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Evaluate new data on the management of iron deficiency in acute decompensated heart failure.
    • Identify clinical practice changes for the management of iron deficiency in acute decompensated heart failure based on new data. 
  • Target Audience

    This activity is designed to meet the educational needs of heart failure specialists, cardiologists, primary care physicians, nephrologists, and all other allied healthcare professionals involved in the diagnosis, treatment, and care of heart failure.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.

  • Commercial Support

    This activity is supported by an independent educational grant from Vifor Pharma.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Programs 9/25/21